151 related articles for article (PubMed ID: 31981784)
1. Evaluation of the Prognosis of Neuroglioma Based on Dynamic Magnetic Resonance Enhancement.
Li F; Zhang Y; Wang N; Song C; Gao Y; Diao X; Zhang H
World Neurosurg; 2020 Jun; 138():663-671. PubMed ID: 31981784
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Factor in Elderly Patients with High-Grade Gliomas.
Gan Y; Zhou X; Niu X; Li J; Wang T; Zhang H; Yang Y; Liu Y; Mao Q
World Neurosurg; 2019 Jul; 127():e261-e267. PubMed ID: 30898756
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
4. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
5. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas.
Eseonu CI; ReFaey K; Garcia O; Raghuraman G; Quinones-Hinojosa A
World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263
[TBL] [Abstract][Full Text] [Related]
6. Maximal tumor diameter in the preoperative tumor magnetic resonance imaging (MRI) T2 image is associated with prognosis of Grade II Glioma.
Liu H; Shen L; Huang X; Zhang G
Medicine (Baltimore); 2021 Mar; 100(10):e24850. PubMed ID: 33725839
[TBL] [Abstract][Full Text] [Related]
7. Progressive Low-Grade Glioma: Assessment of Prognostic Importance of Histologic Reassessment and MRI Findings.
Narang AK; Chaichana KL; Weingart JD; Redmond KJ; Lim M; Olivi A; Quinones-Hinojosa A; Kleinberg LR
World Neurosurg; 2017 Mar; 99():751-757. PubMed ID: 27108796
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and survival study in high-grade glioma in the elderly.
Álvarez de Eulate-Beramendi S; Álvarez-Vega MA; Balbin M; Sanchez-Pitiot A; Vallina-Alvarez A; Martino-González J
Br J Neurosurg; 2016 Jun; 30(3):330-6. PubMed ID: 26828095
[TBL] [Abstract][Full Text] [Related]
9. Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.
Dworkin M; Mehan W; Niemierko A; Kamran SC; Lamba N; Dietrich J; Martinez-Lage M; Oh KS; Batchelor TT; Wen PY; Loeffler JS; Shih HA
J Neurooncol; 2019 Mar; 142(1):69-77. PubMed ID: 30488294
[TBL] [Abstract][Full Text] [Related]
10. Quantitative dynamic susceptibility contrast perfusion-weighted imaging-guided customized gamma knife re-irradiation of recurrent high-grade gliomas.
Wang B; Zhao P; Zhang Y; Ge M; Lan C; Li C; Pang Q; Xu S; Liu Y
J Neurooncol; 2018 Aug; 139(1):185-193. PubMed ID: 29696532
[TBL] [Abstract][Full Text] [Related]
11. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis.
Catalán-Uribarrena G; Bilbao-Barandica G; Pomposo-Gaztelu I; Undabeitia-Huertas J; Ruiz de Gopegui-Ruiz E; Galbarriatu-Gutiérrez L; Canales-Llantada M; Aurrecoechea-Obieta J; Igartua-Azkune A; Carbayo-Lozano G
Acta Neurochir (Wien); 2012 Feb; 154(2):211-22; discussion 222. PubMed ID: 22002506
[TBL] [Abstract][Full Text] [Related]
13. The polymorphisms (rs3213801 and rs5744533) of DNA polymerase kappa gene are not related with glioma risk and prognosis: A case-control study.
Wu Y; Zhou L; Deng Y; Li N; Yang P; Dong S; Yang S; Zheng Y; Yao L; Zhang M; Zhai Z; Dai Z; Wu Y
Cancer Med; 2019 Dec; 8(17):7446-7453. PubMed ID: 31595696
[TBL] [Abstract][Full Text] [Related]
14. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication.
Wei J; Yang G; Hao X; Gu D; Tan Y; Wang X; Dong D; Zhang S; Wang L; Zhang H; Tian J
Eur Radiol; 2019 Feb; 29(2):877-888. PubMed ID: 30039219
[TBL] [Abstract][Full Text] [Related]
15. A multivariate analysis of the prognostic factors of grade III gliomas.
Zhu YJ; Zhu XD; Wang SH; Shen F; Shen H; Liu WG
Chin Med J (Engl); 2008 Jun; 121(12):1072-5. PubMed ID: 18706219
[TBL] [Abstract][Full Text] [Related]
16. Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.
Woo PYM; Ho JMK; Tse TPK; Lam SW; Mak CHK; Chan DTM; Lee MWY; Wong ST; Chan KY; Poon WS
J Clin Neurosci; 2019 May; 63():134-141. PubMed ID: 30712777
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
[TBL] [Abstract][Full Text] [Related]
18. Study of radiochemotherapy decision-making for young high-risk low-grade glioma patients using a macroscopic and microscopic combined radiomics model.
Wu G; Shi Z; Li Z; Xie X; Tang Q; Zhu J; Yang Z; Wang Y; Wu J; Yu J
Eur Radiol; 2024 May; 34(5):2861-2872. PubMed ID: 37889272
[TBL] [Abstract][Full Text] [Related]
19. Permeability Surface Area Product Using Perfusion Computed Tomography Is a Valuable Prognostic Factor in Glioblastomas Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide.
Saito T; Sugiyama K; Ikawa F; Yamasaki F; Ishifuro M; Takayasu T; Nosaka R; Nishibuchi I; Muragaki Y; Kawamata T; Kurisu K
World Neurosurg; 2017 Jan; 97():21-26. PubMed ID: 27693246
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]